Prevention of gastrointestinal bleeding due to stress ulceration: A review of current literature

Anaesthesia and Intensive Care

Volumn 40, Issue 2, 2012, Pages 253-259

  Pilkington, K B ^a   Wagstaff, M J D ^a   Greenwood, J E ^a,b,c,d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b Adelaide Burn Centre   (Australia)

^c Skin Engineering Laboratory   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Burn injury; Histamine 2 receptor antagonists; Proton pump inhibitors; Stress related muscosal disease; Upper gastrointestinal bleeding

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

ACUTE HEPATITIS; AGRANULOCYTOSIS; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BURN PATIENT; CONFERENCE PAPER; CONTINUOUS INFUSION; DIARRHEA; DIZZINESS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; ENTERIC FEEDING; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; INSOMNIA; LIVER FUNCTION TEST; MEDICAL AUDIT; META ANALYSIS (TOPIC); PANCYTOPENIA; PROPHYLAXIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SIDE EFFECT; SOMNOLENCE; STRESS ULCER; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME; VERTIGO;

EID: 84858977011     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000207     Document Type: Conference Paper

References (41)

1. Sloan JM, Correa P, Lindeman J, Meijer CFLM, Sipponen P. The stomach: part 1. Acute hemorrhagic gastritis and acute infective gastritis; gastritis caused by physiological agents and corrosives; uremic gastritis. In: Whitehead R, ed. Gastrointestinal and Oesophageal Pathology. New York, Churchill Livingstone 1995. p. 461-485.
2. Shuman RB, Schuster DP, Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med 1987; 106:562-567. (Pubitemid 17095045)
3. Spirit MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 2004; 26:197-213.
4. Maier RV, Mitchell D, Gentilello L. Optimal therapy for stress gastritis. Ann Surg 1994; 220:353-363. (Pubitemid 24313228)
5. Cook DJ, Reeve BK, Guyatt GH, Marshall JC, Heyland DK, Griffith LE et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996; 275:308-314.
6. Daley RJ, Reubuck JA, Welage LS, Rogers FB. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004; 32:2008-2013. (Pubitemid 39372533)
7. ASHP Board of Directors. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health-Syst Pharm 1999; 56:347-379.
8. Wurzer H, Schutze K, Bethke T, Fischer R, Luhmann R, Riesenhuber C. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group. Hepatogastroenterology 1999; 46:1809-1815. (Pubitemid 29366351)
9. MacLaren R, Jarvis CL, Fish DN. Use of enteral nutrition for stress ulcer prophylaxis. Ann Pharmacother 2001; 35:1614-1623. (Pubitemid 34027465)
10. Powell H, Morgan M, Li SK, Baron JH. Inhibition of gastric acid secretion in the intensive care unit after coronary artery bypass graft. A pilot control study of intravenous omeprazole by bolus and infusion, ranitidine and placebo. Theor Surg 1993; 8:125-130. (Pubitemid 23237641)
11. Levy MJ, Seelig CB, Robinson NJ, Ranney JE. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997; 42:1255-1259. (Pubitemid 27343453)
12. Phillips JO, Metzler MH, Huckfeldt RE, Olsen K. A multicentre, prospective, randomized clinical trial of continuous infusion IV ranitidine vs. Omeprazole suspension in the prophylaxis of stress ulcers. Crit Care Med 1998; 26:101A.
13. Azevedo JR, Soares MG, Silva G, Palacio G. Prevention of stress ulcer bleeding in high risk patients. Comparison of three drugs. Crit Care Med 1999; 27:A145.
14. Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H et al. Stress ulcer prophylaxis in critically ill patients: A randomized controlled trial. Hepatogastroenterology 2004; 51:757-761. (Pubitemid 38590958)
15. Conrad SA, Gabrielli A, Margolis B, Quartin A, Hata JS, Frank WO et al. Randomized, double-blind comparison of immediate release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005; 33:760-765.
16. Somberg L, Morris J, Fantus R, Graepel J, Field BG, Lynn R et al. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. J Trauma 2008; 64:1202-1210. (Pubitemid 351671213)
17. Lin P, Chia-Hsuin C, Ping-I H, Pi-Lai T, Yaw-Bin H. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med 2010; 38:1197-1205.
18. Pongprasobchai S, Kridkratoke S, Nopmaneejumruslers C. Proton Pump Inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis. J Med Assoc Thai 2009; 92:632-637.
19. Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med 2010; 38:2222-2228.
20. Zhou JF, Wan XY, Huang W, Han LL. Bleeding and pneumonia in intensive care units given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a meta-analysis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010; 22:221-225.
21. Hastings PR, Skillmann JJ, Bushnell LS, Silen W. Antacid titration in the prevention of acute gastro-intestinal bleeding: a controlled randomized trial in 100 critically ill patients. N Engl J Med 1978; 298:1041-1045. (Pubitemid 8362282)
22. Hurlimann S, Abbuhl B, Inauen W, Halter F. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 1994; 8:193-201. (Pubitemid 24220596)
23. Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med 1999; 27:2812-2817. (Pubitemid 30027202)
24. Driks MR, Craven DE, Celli BR, Manning M, Burke RA, Garvin GM et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine 2 receptor blockers. The role of gastric colonization. N Engl J Med 1987; 317:1376-1382. (Pubitemid 18052344)
25. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009; 301:2120-2128.
26. Cantu TG, Korek JS. Central nervous system reactions to histamine 2 receptor blockers. Ann Int Med 1991; 114:1027-1034.
27. Aymard JP, Aymard B, Netter P, Bannwarth B, Trechot P, Streiff F. Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol Adverse Drug Exp 1988; 3:430-448. (Pubitemid 19013532)
28. Smythe MA, Zarowitz BJ. Changing perspectives of stress gastritis prophylaxis. Ann Pharmacother 1994; 28:1073-1085. (Pubitemid 24292699)
29. Freston JW. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective. Am J Gastroenterol 1997; 92:51S-57S. (Pubitemid 27197958)
30. Wilmore DW. Nutrition and metabolism following thermal injury. Clin Plast Surg 1974; 1:603-619.
31. Maejima K, Deitch EA, Berg R. Promotion by burn stress of the translocation of bacteria from the gastrointestinal tracts of mice. Arch Surg 1984; 119:166-172. (Pubitemid 14181692)
32. Gottschlich MM, Jenkins ME, Mayes T, Khoury J, Kagan RJ, Warden GD. The 2002 Clinical Research Award. An evaluation of the safety of enteral support and effects on clinical, nutritional, and endocrine outcomes after severe burns. J Burn Care Rehabil 2002; 23:401-415. (Pubitemid 35453587)
33. Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, Stobberingh EE. Continuous enteral feeding counteracts preventative measures for gastric colonisation in intensive care patients. Crit Care Med 1994; 22:939-944. (Pubitemid 24182723)
34. McDonald WS, Sharp CW, Deitch EA. Immediate Enteral Feeding in Burns Patients is safe and Effective. Ann Surg 1991; 213:177-183.
35. Raff T, Germann G, Hartman B. The value of early enteral nutrition in the prophylaxis of stress ulceration in the severely burned patient. Burns 2008; 34:192-196.
36. Lam NN, Tien NG, Khoa CM. Early enteral feeding for burned patients - an effective method which should be encouraged in developing countries. Burns 2008; 34:192-196. (Pubitemid 351163452)
37. Yenikomshian H, Reiss M, Nabavian R, Garner WL. Gastric Feedings Effectively Prophylax Against Upper Gastrointestinal Haemorrhage in Burn Patients. J Burn Care Res 2011; 32:263-268.
38. Liu YL, Yuan KJ. Prevention of stress ulcer bleeding with cimetidine in severe burns. Burns Incl Therm Inj 1983; 9:327-329.
39. van den Berg B, van Blankenstein. Prevention of stress-induced upper gastrointestinal bleeding by cimetidine in patients on assisted ventilation. Digestion 1985; 31:1-8.
40. Apte NM, Karnad DR, Medhekar TP, Tilve G, Gundu H, Morye S et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: A randomized controlled trial. Crit Care Med 1992; 20:590-593.
41. Ben-Menachem T, Fogel R, Patel RV, Touchette M, Zarowitz BJ, Hadzijahic N et al. Prophylaxis for stress-related gastric haemorrhage in the medical intensive care unit. A randomized controlled single-blind study. Ann Int Med 1994; 121:568-575.